Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136714) titled 'Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Maj Vinberg
Condition:
Major Depressive Disorder
Intervention:
Drug: Semaglutide Injectable Product
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 1, 2025
Target Sample Size: 116
Countries of Recruitment:
Denmar...